Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia · Delayed Price · Currency is SAR 95.50
-0.75 (-0.78%)
Aug 13, 2026, 3:19 PM AST
Nahdi Medical Company Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Nahdi Medical Company stock has a consensus rating of "Buy" and an average price target of SAR 121.52. The average 1-year stock price forecast is 27.25% higher than the current stock price, while the lowest is SAR 100.00 (+4.71%) and the highest is SAR 142.00 (+48.69%).
Price Target: SAR 121.52 (+27.25%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nahdi Medical Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 9 | 9 |
Financial Forecast
Revenue This Year
10.92B
from 10.21B
Increased by 6.90%
Revenue Next Year
11.67B
from 10.92B
Increased by 6.85%
EPS This Year
6.30
from 6.39
Decreased by -1.36%
EPS Next Year
6.80
from 6.30
Increased by 7.89%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.